Could these antiviral pills treat long COVID?
Could Paxlovid solve one of the pandemic's biggest puzzles? A new study at Stanford University aims to find out.
Nov 25, 2022
0
28
Could Paxlovid solve one of the pandemic's biggest puzzles? A new study at Stanford University aims to find out.
Nov 25, 2022
0
28
Researchers have developed a comprehensive database of drugs that could be repurposed to tackle mutated SARS-CoV-2 viruses, narrowing the search from thousands to a select few candidates. The research is published in the ...
Nov 21, 2022
0
46
Monkeypox has infected more than 77,000 people in more than 100 countries worldwide, and—similar to COVID-19—mutations have enabled the virus to grow stronger and smarter, evading antiviral drugs and vaccines in its mission ...
Nov 4, 2022
0
46
Black and Hispanic patients are less likely to be given antiviral drugs such as Paxlovid to help battle a bout of COVID-19 than white patients are, a new government report shows.
Oct 28, 2022
1
8
Between 10 and 20 million people worldwide are infected with hepatitis D virus (HDV). HDV infection is always associated with hepatitis B virus infection. So far there has been no satisfactory therapeutic option for this ...
Oct 3, 2022
0
49
Here is a list of the winners of the Nobel Medicine Prize in the past 10 years:
Oct 3, 2022
0
4
The billions of immune cells that help protect us from diseases do amazing things, but sometimes they need a little boost. For decades, scientists have been trying to figure out ways to engineer living immune cells to better ...
Sep 10, 2022
0
147
Hepatitis B virus (HBV) infection is global in nature and induces several liver diseases, such as chronic hepatitis B (CHB), cirrhosis of the liver (LC) and hepatocellular carcinoma (HCC). A total of 882,000 patients died ...
Sep 5, 2022
0
15
Paxlovid and Molnupiravir, two leading COVID-19 antiviral medications, are life-saving drugs that have been shown to reduce deaths, in Paxlovid's case, by a factor of 10 in the most severe cases.
Aug 25, 2022
0
10
Researchers at McMaster University have found a class of well-known antiviral drugs could be part of a one-two punch to treat seasonal influenza and prevent a flu pandemic when used in combination with antibody therapies.
Aug 16, 2022
0
26